Covered recipient · General Payments record
SREENIVAS RAMDAS CHITTOOR
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$31,234.50
- Reported across 102 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $3,347.50 | 3 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,140.00 | 2 |
| Travel and Lodging | $1,173.51 | 5 |
| Education | $850.00 | 1 |
| Food and Beverage | $845.06 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ROCHE MOLECULAR SYSTEMS, INC. | $3,750.79 | 6 |
| Acerta Pharma LLC | $1,522.72 | 3 |
| BeiGene USA, Inc. | $1,262.58 | 2 |
| Karyopharm Therapeutics Inc. | $1,100.00 | 2 |
| ADC Therapeutics America, Inc. | $194.24 | 3 |
| Roche Diagnostics Corporation | $136.34 | 2 |
| Sirtex Medical Inc | $61.15 | 3 |
| ABBVIE INC. | $51.27 | 3 |
| Kite Pharma, Inc. | $45.32 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $43.34 | 2 |
| Tempus AI, Inc | $38.64 | 1 |
| PFIZER INC. | $30.10 | 2 |
| Sumitomo Pharma America, Inc. | $26.81 | 1 |
| Gilead Sciences, Inc. | $23.59 | 1 |
| SOBI, INC | $21.21 | 1 |
| Lilly USA, LLC | $17.02 | 1 |
| E.R. Squibb & Sons, L.L.C. | $15.61 | 1 |
| Stemline Therapeutics Inc. | $15.34 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (37)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.